Biolife Solutions Announces Preliminary Unaudited Revenue Results for Fourth Quarter and Full Year 2023
For the year, the company reported revenue for the full year 2023 was $143.3 million, a decrease of 11% from $161.8 million for 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.55 USD | +0.40% | +3.71% | +7.60% |
1st Jan change | Capi. | |
---|---|---|
+7.60% | 792M | |
-4.29% | 184B | |
-1.78% | 107B | |
-2.72% | 67.52B | |
+0.92% | 50.06B | |
+9.98% | 45.67B | |
+3.40% | 41B | |
+2.47% | 26.73B | |
+3.39% | 26.47B | |
+15.23% | 25.05B |